Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
CytoDyn Inc CYDY
(Total Views: 533)
Posted On: 11/24/2025 1:10:20 PM
Post# of 158771
Posted By: twinter11
Re: Boatbuilder #158642
i dont think so.

heres what i put on livimmune a while back.
if interested.

" Dr. Dolezal was an Assistant Medical Director/Clinical Scientist in BioOncology Therapeutics at Genentech where she worked on late stage and early phase first in human clinical trials with targeted cancer therapies based on the science of cancer signaling pathways. She also worked at the Stanford School of Medicine in the breast cancer clinic while at Genentech as she has a special interest in women's malignancies.

Dr. Dolezal is a board-certified hematologist-oncologist with Stanford Medicine Cancer Center in Emeryville and a clinical associate professor in the Stanford School of Medicine, Division of Oncology

She has one interview (from 10 months back)

https://www.youtube.com/watch?v=BYTniFHL3FI

It started sounding interesting at the 9 minute mark but this video was just a little too early to discuss what she will be discussing at San Antonio

I would love to hear her discuss blocking CCR5 and Leronlimab right now.

But gotta wait till December

PS. This Lady knows her stuff!













(3)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site